260 related articles for article (PubMed ID: 2204199)
1. [The role of humoral antibodies in the rejection of a kidney allograft (a review of the literature)].
Drannik GN; Driianskaia VE
Vrach Delo; 1990 May; (5):45-9. PubMed ID: 2204199
[No Abstract] [Full Text] [Related]
2. Soluble HLA and anti-idiotypic antibodies in transplantation: modulation of anti-HLA antibodies by soluble HLA antigens from the graft and anti-idiotypic antibodies in renal and cardiac allograft recipients.
Suciu-Foca N; Ho E; King DW; Yu YP; Yu-Kai S; Reed E; Cohen D; Brensilver JM; McCabe R; Rose E
Transplant Proc; 1991 Feb; 23(1 Pt 1):295-6. PubMed ID: 1990536
[No Abstract] [Full Text] [Related]
3. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
Galili U
Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
[TBL] [Abstract][Full Text] [Related]
4. Effect of anti-HLA antibodies on the long-term survival of heart and kidney allografts.
Barr ML; Cohen DJ; Benvenisty AI; Hardy M; Reemtsma K; Rose EA; Marboe CC; D'Agati V; Suciu-Foca N; Reed E
Transplant Proc; 1993 Feb; 25(1 Pt 1):262-4. PubMed ID: 8438294
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human erythropoietin decreases anti-HLA sensitization and may improve renal allograft outcome: involvement of anti-idiotypic antibody.
Grimm PC; Sekiya NM; Robertson LS; Robinson BJ; Ettenger RB
Transplant Proc; 1991 Feb; 23(1 Pt 1):407-8. PubMed ID: 1990568
[No Abstract] [Full Text] [Related]
6. ABO antibodies.
Zmijewski CM
Transplantation; 1994 Jun; 57(12):1824. PubMed ID: 8016891
[No Abstract] [Full Text] [Related]
7. [Humoral antibody-mediated rejection in kidney transplants].
Teraoka S; Kai K
Nihon Jinzo Gakkai Shi; 2005; 47(5):497-507. PubMed ID: 16130404
[No Abstract] [Full Text] [Related]
8. Acute and hyperacute humoral rejection in kidney allograft recipients treated with anti-human thymocyte antibodies.
Colovai AI; Vasilescu ER; Foca-Rodi A; Kim-Schulze S; Hussaini N; D'agati VD; Markowitz GS; Wang C; Cohen DJ; Hardy MA; Suciu-Foca N
Hum Immunol; 2005 May; 66(5):501-12. PubMed ID: 15935887
[TBL] [Abstract][Full Text] [Related]
9. Anti-donor's B lymphocytes and anti-IgG antibodies in kidney allograft recipients: correlative study with the transplant outcome.
de Mouzon A; Soulillou JP; Blanc M; Durand D; Ohayon E; Ducos J
Transplant Proc; 1979 Jun; 11(2):1267-8. PubMed ID: 382504
[No Abstract] [Full Text] [Related]
10. Anti-glutathione S-transferase T1 antibody-mediated rejection in C4d-positive renal allograft recipients.
Aguilera I; Alvarez-Marquez A; Gentil MA; Fernandez-Alonso J; Fijo J; Saez C; Wichmann I; Nuñez-Roldan A
Nephrol Dial Transplant; 2008 Jul; 23(7):2393-8. PubMed ID: 18308775
[TBL] [Abstract][Full Text] [Related]
11. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
[TBL] [Abstract][Full Text] [Related]
12. Antibody-mediated rejection: treatment alternatives and outcomes.
Singh N; Pirsch J; Samaniego M
Transplant Rev (Orlando); 2009 Jan; 23(1):34-46. PubMed ID: 19027615
[TBL] [Abstract][Full Text] [Related]
13. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
[TBL] [Abstract][Full Text] [Related]
14. Influence of pretransplant antibodies on early renal allograft rejection.
Alarif L; Rodriguez R; Blackburn S; Light JA
Transplant Proc; 1987 Feb; 19(1 Pt 1):771-2. PubMed ID: 3274869
[No Abstract] [Full Text] [Related]
15. Progress in understanding humoral rejection in kidney transplantation: implications for patient management.
Pascual MA; Crespo M; Tolkoff-Rubin N
Nefrologia; 2001; 21(4):327-31. PubMed ID: 11816504
[TBL] [Abstract][Full Text] [Related]
16. Specific intravenous carbohydrate therapy: a new approach to the inhibition of antibody-mediated rejection following ABO-incompatible allografting and discordant xenografting.
Cooper DK; Good AH; Ye Y; Koren E; Oriol R; Ippolito RM; Malcolm AJ; Neethling FA; Romano E; Zuhdi N
Transplant Proc; 1993 Feb; 25(1 Pt 1):377-8. PubMed ID: 8438342
[No Abstract] [Full Text] [Related]
17. Antibody-mediated rejection.
Akalin E; Watschinger B
Semin Nephrol; 2007 Jul; 27(4):393-407. PubMed ID: 17616272
[TBL] [Abstract][Full Text] [Related]
18. [Post-transplantation anti-HLA antibodies: which relevance?].
Glotz D
Nephrol Ther; 2008 Jun; 4 Suppl 1():S8-S12. PubMed ID: 18703400
[TBL] [Abstract][Full Text] [Related]
19. Specific humoral rejection of a pancreas allograft in a recipient of pancreas after kidney transplantation.
Carbajal R; Karam G; Renaudin K; Maillet F; Cesbron A; Rostaing L; Cantarovich D; Soulillou JP; Blancho G
Nephrol Dial Transplant; 2007 Mar; 22(3):942-4. PubMed ID: 17210592
[No Abstract] [Full Text] [Related]
20. Antibody-mediated rejection of an HLA-identical, ABO-incompatible kidney transplant after two failed cadaver transplants.
Fryer JP; Benedetti E; Perry EH; Matas AJ
Transplantation; 1994 Sep; 58(6):723-5. PubMed ID: 7940694
[No Abstract] [Full Text] [Related]
[Next] [New Search]
